The present invention provides the use of impact resistant, stress cracking resistant copolycarbonates with particularly good low temperature properties for applications in which particularly good low temperature properties are required, e.g., for automobile construction or external applications, and new copolycarbonates themselves.

The invention relates to a method of antagonizing GLP-1 activity in a mammalian patient, comprising administering to said patient an effective amount of a compound of the general formula I: ##STR1## wherein R.sub.1 and R.sub.2 independently of each other are C.sub.1-4 alkyl, R.sub.3 is halogen, hydroxy, C.sub.1-4 -alkoxy or trifluoromethoxy, R.sub.4 is hydrogen, hydroxy or C.sub.1-4 -alkoxy, or a pharmacologically acceptable salt thereof. The invention also relates to a pharmaceutical compositio...

A compound of the general formula (I): ##STR1## wherein R.sub.1, R.sub.2, X, Y and Z are as described in the specification.

There is provided use of a pectin composition to prepare an aqueous composition having high yield stress characteristics without substantial gelation, wherein the pectin composition comprises at least a population of pectin that is calcium sensitive; wherein the pectin composition is capable of imparting high yield stress characteristics to an aqueous composition without causing substantial gelation of the aqueous composition.

The invention features pharmaceutical compositions that include hydroxyguanidines. The compositions can be used, for example, for treating or preventing ischemic diseases, hypoxia,or arrhythmias.

The present invention relates to simplified synthesis, new carbohydrate-based products and practical use of different carbohydrate-based products. Examples of these are (Gal.alpha.1-3Gal), GlcNAc.beta.1-3Gal, .alpha.- or .beta.-glycosides thereof, Gal.alpha.1-3Gal- containing tri-, or higher oligosaccharides, .alpha.- or .beta.-glycosides thereof, GlcNAc.beta.1-3Gal containing tri-, tetra-, or higher oligosaccharides, and derivatives and/or .alpha.- or .beta.-glycosides thereof, Gal.alpha.1-3Gal...

Use of an extract derived from the fruits, leaves, the bark or the roots of Morinda citrifolia L. for the manufacture of a medicament for the treatment of a mammal suffering from tinnitus. The extract may be a liquid present in the medicament in an amount such as to give a daily dosage of 0.1-2 ml, or 0.2-1 ml, e.g. 0.4-0.7 ml, per kg body weight of the patient. The extract also may be a solid present in the medicament in an amount such as to give a daily dosage of 5-200 mg, or 10-100 mg, e.g. 2...

The present invention relates generally to the field of neurobiology. More particularly, the invention relates to the discovery of a new family of proteins and their relation to signal transduction, vesicle trafficking, and diseases associated with aberrations in membrane biosynthesis and organization.

A process for reducing carbonaceous deposits caused by the combustion of heavy fuel oil in high-compression, spontaneous-ignition internal combustion engines involves adding an additive such as ferrocene or ethyl ferrocene to a heavy fuel oil having a density of 0.9 to 1.01 kg/dm.sup.3 in an amount of 1 to 100 ppm prior to combustion of the fuel oil and combusting the fuel oil in the high-compression, spontaneous-ignition internal combustion engine. The additive is dissolved in the heavy fuel oi...

Acetals are used as a mineral oil substitute, oil component or base oil in invert-emulsion drilling muds, emulsion drilling muds, engine oils, gearbox oils, lubricating oils and also metal-working fluids, coolants, cooling lubricants and hydraulic fluids. As compared with conventional mineral oils, acetals show good biodegradability and are less toxic.